Clinical Trial Update: Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract [Phase 2]

View source ↗

Summary

Phase 2 trial of Taxoprexin for advanced primary cancers of the liver, gallbladder, or biliary tract was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Taxoprexin

Snippet

Sponsor: American Regent, Inc. | Conditions: Cancer of the Liver | Phase 2 | Status: TERMINATED